Show simple item record

dc.contributor.authorLyimo, Beatus
dc.contributor.authorPopkin-Hall, Zachary
dc.contributor.authorGiesbrecht, David
dc.contributor.authorMandara, Celine
dc.contributor.authorMadebe, Rashid
dc.contributor.authorBakari, Catherine
dc.contributor.authorPereus, Dativa
dc.contributor.authorSeth, Misago
dc.contributor.authorNgamba, Ramadhan
dc.contributor.authorMbwambo, Ruth
dc.contributor.authorMacInnis, Bronwyn
dc.contributor.authorMbwambo, Daniel
dc.contributor.authorGarimo, Issa
dc.contributor.authorChacky, Frank
dc.contributor.authorAaron, Sijenunu
dc.contributor.authorLusasi, Abdallah
dc.contributor.authorMolteni, Fabrizio
dc.contributor.authorNjau, Ritha
dc.contributor.authorCunningham, Jane
dc.contributor.authorLazaro, Samwel
dc.contributor.authorMohamed, Ally
dc.contributor.authorJuliano, Jonathan
dc.contributor.authorBailey, Jeffrey
dc.contributor.authorIshengoma, Deus
dc.date.accessioned2023-10-24T07:09:17Z
dc.date.available2023-10-24T07:09:17Z
dc.date.issued2022-07-13
dc.identifier.urihttps://doi.org/10.3389/fcimb.2022.757844
dc.identifier.urihttps://dspace.nm-aist.ac.tz/handle/20.500.12479/2349
dc.descriptionA research article was submitted to Clinical Microbiology Volume 12 - 2022en_US
dc.description.abstractRecent developments in molecular biology and genomics have revolutionized biology and medicine mainly in the developed world. The application of next generation sequencing (NGS) and CRISPR-Cas tools is now poised to support endemic countries in the detection, monitoring and control of endemic diseases and future epidemics, as well as with emerging and re-emerging pathogens. Most low and middle income countries (LMICs) with the highest burden of infectious diseases still largely lack the capacity to generate and perform bioinformatic analysis of genomic data. These countries have also not deployed tools based on CRISPR-Cas technologies. For LMICs including Tanzania, it is critical to focus not only on the process of generation and analysis of data generated using such tools, but also on the utilization of the findings for policy and decision making. Here we discuss the promise and challenges of NGS and CRISPR-Cas in the context of malaria as Africa moves towards malaria elimination. These innovative tools are urgently needed to strengthen the current diagnostic and surveillance systems. We discuss ongoing efforts to deploy these tools for malaria detection and molecular surveillance highlighting potential opportunities presented by these innovative technologies as well as challenges in adopting them. Their deployment will also offer an opportunity to broadly build in-country capacity in pathogen genomics and bioinformatics, and to effectively engage with multiple stakeholders as well as policy makers, overcoming current workforce and infrastructure challenges. Overall, these ongoing initiatives will build the malaria molecular surveillance capacity of African researchers and their institutions, and allow them to generate genomics data and perform bioinformatics analysis in-country in order to provide critical information that will be used for real-time policy and decision-making to support malaria elimination on the continent.en_US
dc.language.isoenen_US
dc.publisherFrontiersen_US
dc.subjectnext generation sequencingen_US
dc.subjectCRISPR-Cas systemsen_US
dc.subjectpathogen genomicsen_US
dc.subjectmalaria diagnosisen_US
dc.subjectmalaria molecular surveillanceen_US
dc.titlePotential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record